n-methyladenosine has been researched along with Bladder Cancer in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 9 (69.23) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Li, Y; Xu, L; Yang, J; Yi, W; Yu, Y | 1 |
| Liu, X; Ma, T; Meng, L; Tian, Z; Wang, J; Wang, X; Zhang, W; Zhang, Y | 1 |
| Wang, JC; Wang, XD; Wang, XJ; Wang, YL; Xue, MQ; Zhang, YQ | 1 |
| Chao, Y; Ji, W; Jin, H; Lin, S; Min, W; Qi, D; Que, B; Wang, X; Yang, M; Ying, X; Yuan, Z; Zhang, H | 1 |
| Gu, C; Kou, Y; Li, G; Luo, Y; Tian, F; Wang, Y; Wang, Z; Yang, J; Zhou, N | 1 |
| Cao, H; Chen, M; Gao, YH; Nie, ZY; Wen, XH; Zhang, SF | 1 |
| Chu, H; Du, M; Fu, G; Ge, Y; Gu, J; Jin, Y; Liu, H; Lv, Q; Ma, G; Qin, C; Wang, M; Yuan, L; Yuan, Q; Zhang, Z | 1 |
| Huang, Y; Ji, W; Jiang, X; Liu, B; Luo, J; Qi, D; Ying, X; Yuan, G; Zhang, H; Zhu, X | 1 |
| Gao, Y; Gao, Z; Luo, J; Song, W; Yang, K | 1 |
| Chen, X; He, W; Niu, Z; Wang, J; Yao, Z; Zhao, G; Zheng, B | 1 |
| Huang, C; Jiang, G; Liu, F; Sun, J; Xiao, X; Xie, F; Zhang, H; Zhang, X | 1 |
| Li, G; Lin, G; Wu, Y; Zhang, J; Zhu, S | 1 |
| Han, J; Lu, HC; Lu, JC; Lu, Q; Wang, JZ; Wei, JF; Yang, H; Yang, X; Yu, H; Yuan, WB; Zhou, R; Zhou, ZJ | 1 |
13 other study(ies) available for n-methyladenosine and Bladder Cancer
| Article | Year |
|---|---|
The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Topics: Adenosine; Aged; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Cell Line, Tumor; Female; Humans; Male; Methylation; Middle Aged; PTB-Associated Splicing Factor; RNA, Messenger; Urinary Bladder Neoplasms | 2021 |
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Topics: Adenosine; Disease Progression; Humans; Immune Checkpoint Proteins; Lymphocytes, Tumor-Infiltrating; Neoplasm Staging; Prognosis; Proportional Hazards Models; RNA-Seq; RNA, Long Noncoding; Survival Rate; Transcriptome; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer.
Topics: Adenosine; B7-H1 Antigen; Humans; RNA, Long Noncoding; Tumor Microenvironment; Urinary Bladder Neoplasms | 2022 |
N
Topics: Adenosine; Adult; Aged; AlkB Homolog 5, RNA Demethylase; Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Integrin alpha6; Male; Methyltransferases; Mice; Middle Aged; Neoplasm Grading; Neoplasm Staging; RNA, Messenger; Urinary Bladder Neoplasms | 2019 |
Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N
Topics: Adenosine; Cell Self Renewal; Cell Transformation, Neoplastic; Gene Expression; Gene Knockdown Techniques; Humans; Immunohistochemistry; Methyltransferases; Neoplastic Stem Cells; Prognosis; Receptor, Notch1; RNA Stability; Urinary Bladder Neoplasms | 2019 |
m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
Topics: Adenosine; Biomarkers, Tumor; Disease-Free Survival; Female; Humans; Male; Methylation; RNA, Neoplasm; Survival Rate; Urinary Bladder Neoplasms | 2019 |
Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.
Topics: Adenosine; Aged; Asian People; Case-Control Studies; China; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Male; Middle Aged; Molecular Epidemiology; Phenotype; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Superoxide Dismutase; Urinary Bladder Neoplasms | 2021 |
Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development.
Topics: Adenosine; Antigens, Neoplasm; Carcinogenesis; Cell Adhesion Molecules; Cell Line, Tumor; CRISPR-Cas Systems; Humans; Methyltransferases; Protein Biosynthesis; RNA, Messenger; Urinary Bladder Neoplasms | 2020 |
Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinogenesis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; delta-1-Pyrroline-5-Carboxylate Reductase; Disease Progression; Gene Knock-In Techniques; Gene Knockdown Techniques; Humans; Methylation; Mice; Neoplasm Staging; Neoplasm Transplantation; Pyrroline Carboxylate Reductases; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Ubiquitin Thiolesterase; Urinary Bladder Neoplasms | 2021 |
A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Carcinoma; DNA Methylation; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Methyltransferases; Nuclear Proteins; RNA-Binding Proteins; Urinary Bladder Neoplasms | 2021 |
CircPTPRA blocks the recognition of RNA N
Topics: Adenosine; Animals; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Epigenesis, Genetic; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterografts; Humans; Immunohistochemistry; Mice; Models, Biological; Protein Binding; Receptor-Like Protein Tyrosine Phosphatases, Class 4; RNA-Binding Proteins; RNA, Circular; Urinary Bladder Neoplasms | 2021 |
Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer.
Topics: Adenosine; Biomarkers, Tumor; Humans; Prognosis; Transcriptome; Tumor Microenvironment; Urinary Bladder Neoplasms | 2021 |
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Methyltransferases; Mice; MicroRNAs; Neoplasm Transplantation; PTEN Phosphohydrolase; RNA-Binding Proteins; Tissue Array Analysis; Up-Regulation; Urinary Bladder Neoplasms | 2019 |